SCHEMBL21524309

SCHEMBL21524309

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5ccc(-n6c7ccccc7c7c8ccccc8ccc76)cc5)c5ccccc45)cc3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.39
▸ ATM Q13315 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ MAPT P10636 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24154397 0.97 KDM4E (0.37) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL24152085 0.96 KDM4E (0.36) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL24152652 0.95 KDM4E (0.40) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL13087042 0.95 ATM (0.43) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL24152508 0.94 KDM4E (0.39) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL21524307 0.93 ATM (0.42) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL22352388 0.93 ATM (0.42) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL17943428 0.93 ATM (0.42) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL17943398 0.93 ATM (0.42) KDM4EATML3MBTL1MAPTSMN1; SMN2
SCHEMBL17943381 0.93 ATM (0.42) KDM4EATML3MBTL1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10461259-B2 Organic light emitting device LG CHEM, LTD. (KR) 2019-10-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10461259-B2 Organic light emitting device CRY1, CRY2, MAP1LC3C KDM4E 1575/4885ATM 3898/4885L3MBTL1 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback